Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
US Department of Justice
Mallinckrodt
Medtronic
Citi
Fish and Richardson
Cantor Fitzgerald
Moodys

Generated: June 25, 2018

DrugPatentWatch Database Preview

CARDURA Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cardura patents expire, and when can generic versions of Cardura launch?

Cardura is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in CARDURA is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Drug patent expirations by year for CARDURA
Pharmacology for CARDURA
Medical Subject Heading (MeSH) Categories for CARDURA
Synonyms for CARDURA
(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone methanesulfonate
[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone; methanesulfonic acid
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-2-yl)methanone; methanesulfonic acid
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone; methanesulfonic acid
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone;methanesulfonic acid
1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(1,4-BENZODIOXAN-2-YLCARBONYL) PIPERAZINE METHANESULFONATE
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazine monomethanesulfonate
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzoldioxan-2-ylcarbonyl)piperazine methanesulfonate
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(1,4-benzodioxan-2-yl)carbonyl]piperazine Methanesulfonate
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; methanesulfonic acid
2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine mesylate
2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine; methanesulfonic acid
4-Amino-2-[4-(1,4-benzodioxan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazoline methanesulfonate
74191-85-8 (Parent)
77883-43-3
91D858
AB0008587
AB2000045
AC-6848
AC1L1Y5G
AC1Q4GSV
AC1Q4GT3
AKOS015895371
Alfadil
AN-9627
ANW-42738
Benur
Bio-0889
C23H25N5O5.CH4O3S
C24H29N5O8S
Cardenalin
Cardoral
Cardoxan
Cardular
Cardular PP
Cardular Uro
Cardura (TN)
Cardura XL
Cardura;Carduran;Cardura XL
Carduran
Carduran Neo
CAS-77883-43-3
CCG-213583
CHEBI:4709
CHEMBL1200561
CPD000058441
CS-1830
CTK7B4527
D 9815
D00608
D4126
Dedralen
Diblocin
Diblocin PP
Diblocin Uro
Doksura
Dosin
Doxaben
Doxazocine
Doxazomerck
Doxazosin (mesylate)
Doxazosin AZU
Doxazosin mesilate
Doxazosin mesilate (JP17)
Doxazosin mesilate, European Pharmacopoeia (EP) Reference Standard
Doxazosin mesylate
Doxazosin mesylate (USAN)
Doxazosin mesylate [USAN:USP]
Doxazosin mesylate [USAN]
Doxazosin mesylate, >=97% (HPLC), powder
Doxazosin mesylate, United States Pharmacopeia (USP) Reference Standard
DOXAZOSIN; METHANESULFONIC ACID
Doxazosinmesylate
Doxolbran
DR003231
DSSTox_CID_25598
DSSTox_GSID_45598
DSSTox_RID_80991
DTXSID5045598
Duracin
EN300-53021
EU-0100474
FT-0625592
HMS1570L17
HMS2093J14
HMS2097L17
HMS2230L18
HMS3261O10
HMS3372C03
HMS3654J15
HSDB 7082
HY-B0098A
I06-0611
J10294
Kaltensif
KS-1052
LP00474
LS-110229
MFCD00216023
MLS000028455
MLS000120399
MLS001148153
MLS002222292
MLS006011977
MolPort-003-983-427
NCGC00016146-02
NCGC00017136-01
NCGC00018158-09
NCGC00093884-01
NCGC00261159-01
NE52844
Normathen
NSC-759284
NSC759284
Opera_ID_1881
Pharmakon1600-01505976
Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-, monomethanesulfonate
Prestwick_1026
Progandol
Prostadilat
PubChem2385
RW2756
s1324
SAM002589903
SCHEMBL42621
SMR000058441
SR-01000003045
SR-01000003045-2
Supressin
Tensiobas
TL8005338
Tonocardin
Tox21_110796
Tox21_110796_1
Tox21_500474
UK 33,274-27
UK-33,274-27
UK-33274-27
UK-3327427
VJECBOKJABCYMF-UHFFFAOYSA-N
Z1259084903

US Patents and Regulatory Information for CARDURA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-001 Nov 2, 1990 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-004 Nov 2, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-002 Nov 2, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-003 Nov 2, 1990 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for CARDURA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-004 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-001 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-003 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Pfizer CARDURA doxazosin mesylate TABLET;ORAL 019668-002 Nov 2, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Harvard Business School
Accenture
Citi
US Department of Justice
Baxter
Argus Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.